Pentagamavunon-0 (PGV-0) Enhance Cytotoxic Effect of Doxorubicin through Increasing of Apoptosis, Senescence and ROS Level on Triple Negative Breast Cancer 4T1

TNBC, one of the sub type of breast cancers was widely known with high tumorigenic and poor prognosis than others. The development of combination agent (co-chemotherapy) with doxorubicin for chemotherapy of TNBC were carried out to decrease doxorubicin side effect and resistance in cancer. This pres...

Full description

Saved in:
Bibliographic Details
Main Authors: Ismanurrahman Hadi, Riris Istighfari Jenie, Edy Meiyanto
Format: Article
Language:English
Published: Indonesian Society for Cancer Chemoprevention 2020-02-01
Series:ISCC (Indonesian Journal of Cancer Chemoprevention)
Online Access:https://ijcc.chemoprev.org/index.php/ijcc/article/view/302
Tags: Add Tag
No Tags, Be the first to tag this record!